Filter
1730
Text search:
molecular
Featured
Recommendations
204
New Publications
312
Language
Document type
No document type
718
Guidelines
386
Studies & Reports
333
Manuals
111
Strategic & Response Plan
77
Fact sheets
51
Training Material
24
Situation Updates
11
Resource Platforms
10
Infographics
7
Brochures
1
Videos
1
Countries / Regions
India
95
Global
70
Latin America and the Carribbean
66
Brazil
53
Western and Central Europe
50
Eastern Europe
36
Africa
35
Kenya
29
Colombia
28
South Africa
26
Tanzania
24
Ethiopia
21
West and Central Africa
17
Venezuela
17
Russia
17
Peru
15
Uganda
14
Mozambique
14
East and Southern Africa
14
Paraguay
14
Germany
13
Argentina
13
South–East Asia Region
13
Rwanda
12
El Salvador
12
Nigeria
11
Zambia
11
Malawi
11
Namibia
11
Asia
11
Sierra Leone
10
Philippines
10
Nepal
10
Angola
10
Congo, Democratic Republic of
9
Ukraine
9
Bolivia
9
Liberia
8
Senegal
8
Ghana
8
Zimbabwe
7
Indonesia
7
Bangladesh
7
Ecuador
7
Chile
7
Syria
6
Myanmar / Burma
6
Middle East and North Africa
6
Vietnam
6
Spain
6
Pakistan
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Cambodia
4
France
4
Guinea
3
Burkina Faso
3
Haiti
3
Lebanon
3
Thailand
3
China
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
North America
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Somalia
2
South Sudan
2
Jordan
2
Turkey
2
Chad
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Mexico
2
Tajikistan
2
Georgia
2
Uruguay
2
United Kingdom
2
Portugal
2
Morocco
1
Saudi Arabia
1
Iraq
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Cuba
1
Madagascar
1
Lesotho
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Palestine
1
Italy
1
Laos
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Iran
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
569
Clinical Guidelines
207
Public Health
74
Pharmacy & Technologies
69
Key Resources
33
Women & Child Health
19
Capacity Building
11
Toolboxes
TB
357
COVID-19
248
NTDs
152
AMR
104
HIV
94
Mental Health
78
Malaria
53
Ebola & Marburg
46
Rapid Response
45
Planetary Health
39
Zika
31
Pharmacy
30
NCDs
26
2.0 Rapid Response
21
Refugee
16
Polio
13
Specific Hazards
11
Cholera
10
Caregiver
9
Disability
8
Global Health Education
7
Health Financing Toolbox
6
Conflict
4
Natural Hazards
4
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr
...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th
...
The Lancet Regional Health Americas Volume 37100832 September 2024
Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic
recommended
Interim Guidance
This document is to help Member States build on actions taken during the COVID-19 pandemic to improve national medium- to long-term preparedness for future threats. It maps COVID-19 preparedness and response actions to the building of sustainable International Health Regulations (2
...
4–15 February 2013
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ
...
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child
...
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child
...
The use of safe and efficacious insecticides against the adult and larval populations of mosquito vectors is one of the most effective ways to rapidly interrupt transmission of Zika virus, as well as other viruses transmitted by Aedes mosquitoes such as chikungunya and dengue.
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Um Manual Programático
A publicação deste documento foi possível graças ao apoio da Comissão Europeia (auxílio Sante 2007141-838). O conteúdo deste documento é de responsabilidade única de A Union e não reflete a opinião da Comissão Europeia.
Rapport sur les populations clés.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec
...
Other disorders
Chapter H.5.1
Можно выделить две формы энкопреза: энкопрез с запором и без запора. Такое разделение крайне важно, так как в основе этих двух форм лежит разная патофизиология, они
...